Measuring CD11b-positive monocytes could help estimate how many anti-vascular endothelial growth factor injections a patient with neovascular age-related macular degeneration or polypoidal choroidal vasculopathy might need, study findings suggest.
Selective laser trabeculoplasty offers superior intraocular pressure stability to that of eye drops and is more cost-effective when used as a first-line treatment for patients with open angle glaucoma or ocular hypertension, results of the LiGHT trial show.
Both triamcinolone acetonide and bevacizumab improve visual acuity when given as an adjunct to cataract surgery in patients with diabetic macular oedema, but only triamcinolone acetonide results in a sustained anatomical improvement, researchers report.
Retinal nerve fibre layer thinning progresses faster in eyes with lamina cribrosa defects than it does in eyes without such defects, shows an analysis of patients enrolled in the Diagnostic Innovations in Glaucoma Study.
Results of the randomised CANTREAT trial add to increasing evidence that a treat-and-extend ranibizumab regimen results in similar visual outcomes, with fewer injections, than monthly treatment for neovascular age-related macular degeneration.
Statin therapy may reduce the risk of diabetic retinopathy and the need for its associated invasive treatments in patients with type 2 diabetes and dyslipidaemia, population-based study findings indicate.
Researchers have used optical coherence tomography to reveal the development of a fibrosis-like hyper-reflective tissue at the interface between the electronic array and retina in patients who have undergone electronic retinal prosthesis implantation.
The majority of patients with glaucoma appear willing to sign up to receive automated medication reminders linked to their electronic health records, with most describing them as useful, US research shows.
Researchers from the Fight Retinal Blindness! study group have identified a number of variables that predict of sustained loss of visual acuity in patients with neovascular age-related macular degeneration.
Tolerating some subretinal fluid during a treat-and-extend ranibizumab protocol does not detrimentally affect visual acuity in patients with neovascular age-related macular degeneration, study findings indicate.
Developing non-fibrotic scars during the first year of anti-vascular endothelial growth factor treatment does not have a detrimental effect on visual acuity during the following 4 years, US researchers report.
Treatment with fixed-combination brinzolamide 1%/brimonidine 0.2% for 4 weeks significantly reduces 24-hour intraocular pressure in patients with open-angle glaucoma or ocular hypertension, US researchers report.
Current glaucoma staging systems based on 24-2 (or 30-2) visual fields underestimate disease severity and the presence of macular damage when compared with 10-2 visual fields and high-resolution macular imaging, US researchers report.
The majority of patients with chronic non-resolving central serous chorioretinopathy will experience complete resolution following 2 years of treatment with a mineralocorticoid receptor antagonist, study findings indicate.
Agreement between Early Treatment Diabetic Retinopathy Study 7-field imaging and ultrawide-field imaging is moderate when assessing the severity of diabetic retinopathy in patients with type 1 or type 2 diabetes, US research shows.